His neck muscle did improve. But after many weeks of trying to get him to reposition his head we were still having difficulty and began to notice his head shape changing. At around 4 months we went back to the doctor with our concerns. This was the first time we heard the term Plagiocephaly. We were told that he had developed Plagiocephaly but that it would not affect his development in any way and as he grew his hair would cover the flatness.
Information about our journey with treating our son's Plagiocephaly in the UK as well as information I collected along the way.
Wednesday, 18 January 2012
About Evren
His neck muscle did improve. But after many weeks of trying to get him to reposition his head we were still having difficulty and began to notice his head shape changing. At around 4 months we went back to the doctor with our concerns. This was the first time we heard the term Plagiocephaly. We were told that he had developed Plagiocephaly but that it would not affect his development in any way and as he grew his hair would cover the flatness.
How can you help?
Head Start 4 Babies
Loki's Plagiocephaly Awareness Facebook Page
Tuesday, 17 January 2012
Advise from the American Medical Association
The AMA has also issued AMA Policy H-185.967, which declares “that treatment of a minor child's congenital or developmental deformity or disorder due to trauma or malignant disease should be covered by all insurers” and “shall include treatment which, in the opinion of the treating physician, is medically necessary to return the patient to a more normal appearance․” See “Coverage of Children's Deformities, Disfigurement and Congenital Defects,” American Medical Association, AMA Policy H-185.967
Babies with Position-Related Head Flattening May Have Higher Rate of Ear Infections
Babies with Position-Related Head Flattening May Have Higher Rate of Ear Infections
The recommendation to lay babies on their backs to sleep has reduced sudden infant death syndrome (SIDS), but has led to an increased number of infants with a skull deformity called deformational (or positional) plagiocephaly. Now new research suggests that infants with more severe plagiocephaly may have a higher rate of middle ear abnormalities associated with ear infections (otitis media), reports the September issue of The Journal of Craniofacial Surgery. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.
Given the potential impact on hearing and other aspects of child development, more research will be needed to clarify the risk of otitis media in infants with deformational plagiocephaly, according to researcher Adam Purzycki, BS, and colleagues of Wake Forest University Medical Center, Winston-Salem, NC.
Results Suggest Possible Increase in Otitis Media with Severe Plagiocephaly
Children with deformational plagiocephaly have flattening of the back of the head, ranging from mild to severe. In recent years, the number of infants with this form of plagiocephaly has increased exponentially as a result of the "Back to Sleep" campaign to prevent SIDS. The growing skull becomes deformed as a result of pressure from lying in the same position. For most affected infants, treatment consists of a helmet or band to gently mold the growing skull into a more normal shape.
The researchers asked the parents of 1,259 children with deformational plagiocephaly about their child's history of ear infections. Almost exactly half of the children had at least one ear infection before one year old-similar to the rate in the normal population. The rate was slightly higher for children with more severe plagiocephaly: 54 percent, compared to 49 percent in those with milder deformity.
In 124 children, the researchers performed a test called a tympanogram, done to measure pressures within the middle ear. Certain patterns of tympanogram results suggest the presence of otitis media.
The results showed "a marked trend" toward a relationship between otitis media-related abnormalities and the severity of plagiocephaly. "The more severe cases (types IV-V) of plagiocephaly had a higher percentage of otitis media than the less severe cases (types I-III)," the researchers write.
Hearing Loss Could Contribute to Developmental Problems
In more severe plagiocephaly, the skull deformity may cause the ear to move forward. Resulting abnormalities of the eustachian tube may cause problems with fluid drainage from the middle ear, promoting infections and otitis media. "The significantly high percentage of tympanogram readings that pointed to otitis media...suggests an overall malfunction of the middle ear drainage function of the eustachian tube in these children," according to Purzycki and colleagues.
There is growing attention to the possibility of long-term complications related to plagiocephaly, with some studies reporting developmental problems such as language disorders and learning disabilities. The new findings raise the possibility that at least some of these problems could be related to hearing loss-a known complication of persistent otitis media in children.
If so, then recognition and appropriate management of otitis media in children with deformational plagiocephaly might help to reduce these long-term developmental concerns. However, the researchers emphasize the need for more research to clarify the link between plagiocephaly and otitis media-including the clinical significance of the abnormal tympanograms.
About The Journal of Craniofacial Surgery
The Journal of Craniofacial Surgery serves as a forum of communication for all those involved in craniofacial and maxillofacial surgery. Coverage ranges from practical aspects of craniofacial surgery to the basic science that underlies surgical practice. Affiliates include 14 major specialty societies around the world, including the American Association of Pediatric Plastic Surgeons, the American Academy of Pediatrics Section of Pediatric Plastic Surgery, the American Society of Craniofacial Surgeons, the American Society of Maxillofacial Surgeons, the Argentine Society of Plastic Surgery Section of Pediatric Plastic Surgery, the Asian Pacific Craniofacial Association, the Association of Military Plastic Surgeons of the U.S., the Brazilian Society of Craniofacial Surgeons, the European Society of Craniofacial Surgery, the International Society of Craniofacial Surgery, the Japanese Society of Craniofacial Surgery, the Korean Society of Craniofacial Surgery, the Thai Cleft and Craniofacial Association, and the World Craniofacial Foundation.
Frenchay Hosptial
From: Kristian Aquilina
Date: 10 January 2011 17:40:55 GMT
Subject: Treatment for plagiocephaly
Dear Ms Okanay,
Thank you very much for your email. Nitin Patel passed your message on to me as I am one of the paediatric consultants in the department.
I can confirm that we do see children with plagiocephaly on the NHS and we offer them free NHS treatment. The hospital tariff cost for the helmet, which includes a brief anaesthetic to mould the helmet, is £660.
Hope this helps. Please let me know if I there is anything else I can do.
Yours sincerely,
Kristian Aquilina FRCS(SN)
Consultant paediatric neurosurgeon
Department of Neurosurgery
Frenchay Hospital
Bristol.
North Bristol NHS Trust - www.nbt.nhs.uk
Dear Mr Aquilina,
From: Kristian Aquilina
Date: 18 January 2011 15:05:42 GMT
Subject: RE: Treatment for plagiocephaly
Dear Ms Okanay,
Apologies for the delay getting back to you.
We do not use any craniometric criteria. We decide whether to offer the helmet or not on the basis of a full discussion with the parents; we discuss their level of concern on their child's cosmetic appearance, their expectations,and the possible complications and results we have had from our helmet. Of course we do get plain skull x-rays and sometimes even a CT scan to make sure that we are not missing a 'real' craniosynostosis.
Does this help?
Thanks and best wishes,
Kristian.
Nice Guidance (or lack of I should say)
NICE is an independent organisation responsible for providing national guidance for the NHS in the UK on promoting good health and preventing and treating ill health. Our role is to produce guidance (advice) for the NHS on how to treat health conditions.
We were notified of the topic ‘Moulding helmets / cranial banding for plagiocephaly’ (http://guidance.nice.org.uk/IP/313) for consideration under our interventional procedure programme in February 2055 and following consideration of the topic we decided that it did not fall within the remit of this programme.
It may be useful to provide some background information about our Interventional procedures (IP) programme. IP guidance protects patients' safety and support people in the NHS in the process of introducing new procedures. Many of the procedures that NICE investigates are new, but we also look at more established procedures if there is uncertainty about their safety or how well they work. By providing guidance on how safe procedures are and how well they work, NICE makes it possible for new treatments and tests to be introduced into the NHS in a responsible way.
Whilst our interventional procedures guidance makes recommendations on the safety of a procedure and how well it works, it does not cover whether or not the NHS should fund a procedure. Decisions about funding are taken by local NHS bodies (primary care trusts and hospital trusts) after considering how well the procedure works and whether it represents value for money for the NHS.
As you are aware, in accordance with our published methods guides this particular procedure is not within remit because it is not interventional. To fall within the Programme’s remit, a notified procedure must involve an incision or a puncture or entry into a body cavity, or the use of ionising, electromagnetic or acoustic energy.
It is important to note that just because a treatment or procedure has not been assessed by NICE, does not mean that it should not be made available on the NHS. A lack of guidance from NICE is NOT the same as a recommendation against the use of a treatment. There are many treatments available on the NHS which NICE has not appraised. In the absence of NICE guidance PCT’s are expected to make their own decisions about whether or not to provide this procedure, based on their own assessment of its effectiveness.
The Department of Health has issued good practice guidance for Trusts on managing the introduction of new healthcare interventions, and have stated that “It is not acceptable to cite a lack of NICE guidance as a reason for not providing a treatment”. You can download this good practice guidance document via the following page of the DH website: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_064983 . (This quoted text comes from page 4 of the document).
For further information and advice about your own situation, it would be advisable for you to contact Patient Advice and Liaison Service (PALS). As well as providing information about the NHS and dealing with health related enquiries and concerns, your local PALS office can also advise about the NHS complaints procedure and/or appealing a PCT decision (http://www.pals.nhs.uk ).
I hope this information is helpful. Please do not hesitate to contact me again if you have any further questions.
Kind regards
Janet
Janet Fahie
Communications Executive
National Institute for Health and Clinical Excellence
Level 1A | City Tower | Piccadilly Plaza | Manchester M1 4BD | United Kingdom
Tel: 44 (0)845 003 7781 | Fax: 44 (0)845 003 7785
Web: http://nice.org.uk
What the people regulating Doctor and Orthotist in the UK have to say
The General Medical Council is the independent regulator for doctors in the UK. Our statutory purpose is to protect, promote and maintain the health and safety of the public by ensuring proper standards in the practice of medicine.
The law gives us four main functions under the Medical Act 1983:
· keeping up-to-date registers of qualified doctors
· fostering good medical practice
· promoting high standards of medical education and training
· dealing firmly and fairly with doctors whose fitness to practise is in doubt.
Doctors who wish to practice medicine in the UK must be registered with the GMC and, in most cases, hold a licence to practise. We give guidance to doctors on the principles of good practice and the standards we expect them to meet. Serious or persistent failure to follow the guidance will put a doctor_s registration at risk.
Private healthcare providers must also be registered with the Care Quality Commission (www.cqc.org.uk), the independent regulator of health and social care in the UK.
We are not in a position to advise doctors about the suitability or otherwise of particular treatments as our remit does not extend to collecting, analysing or disseminating clinical information. We do not therefore, produce clinical guidance.
However, we expect doctors to follow the advice in Good Medical Practice, our core guidance for doctors, which makes clear that when providing care, doctors must prescribe drugs or treatment only when they have adequate knowledge of the patient_s health, and are satisfied that the drugs or treatment serve the patient_s needs and provide effective treatments based on the best available evidence (paragraph 3(b) and (c)).
We also advise doctors that they must keep their knowledge and skills up to date throughout their working lives and that they should be familiar with relevant guidelines and developments that affect their work. This would include keeping up to date with evidence about the effectiveness of relevant medical treatments. Information about the effectiveness of medical treatments, and the risks and benefits attaching to them, is available from a wide range of sources including government health departments and regulatory agencies, the medical royal colleges, independent organisations such as the National Institute for Health and Clinical Excellence (NICE), medical research journals and other publications.
Doctors must also obtain patient_s consent (or in the case of young children, usually the consent of a parent or parents) before providing any medical treatment. When seeking consent, doctors must give patients the information they want or need so that they can make an informed decision about whether to consent. In our guidance booklet, Consent: patients and doctors making decisions together we set out the information that patients are likely to want or need to know. This includes information about:
· The purpose of any proposed investigation or treatment and what it will involve
· The potential benefits, risks and burdens, and the likelihood of success, for each option
· Whether a proposed investigation or treatment is part of a research programme or is an innovative treatment designed specifically for their benefit
· Their right to seek a second opinion.
There are times when there may be uncertainty about the effectiveness of particular treatments or whether a particular treatment is better than another. In the absence of any definite research or audit evidence, doctors must use their clinical judgement, and the best available evidence, to make decisions about whether the treatment is appropriate for a particular patient.
While we do not require doctors to only provide evidence based treatments to patients, they must be satisfied that any treatment that they provide is in the patient_s best interests. This will generally mean that any known risks of the treatment are outweighed by the potential benefits to the patient. Doctors must always be prepared to explain and justify their actions or decisions including their decisions about treatment for patients.
In addition, Good Medical Practice also makes clear that doctors must not make unjustifiable claims about the quality or outcomes of their services in any information they provide to treatments and it must not offer guarantees of cures, nor exploit patient_s vulnerability or lack of medical knowledge. They must not put pressure on patients to use a service, for example by arousing ill-founded fears for their future health (paragraph 60-62). Nor must they put pressure on patients to accept private treatment (paragraph 72(e)).
I hope that this is helpful in explaining our role and the guidance we expect doctors to follow.
Kind Regards
Suzanne
Suzanne Wood
Policy Adviser
Standards & Ethics Section
The HPC regulates orthotists within the UK. Only
someone who is registered with us can practice as an orthotist or use the
protected title 'orthotist'. We set standards which our registrants have to
meet, including the standards of conduct, performance and ethics (SCPE).
One of the standards within the SCPE says:
"Any advertising you do in relation to your professional activities must be
accurate. Advertisements must not be misleading, false, unfair or
exaggerated. In particular, you should not claim your personal skills,
equipment or facilities are better than anyone else’s, unless you can prove
this is true.
If you are involved in advertising or promoting any product or service, you
must make sure that you use your knowledge, skills and experience in an
accurate and responsible way. You must not make or support unjustifiable
statements relating to particular products. Any potential financial reward
should not play a part in the advice or recommendations of products and
services you give."
The standards of conduct, performance, and ethics can be found here on our
website:
http://www.hpc-uk.org/aboutregistration/standards/standardsofconductperformanceandethics/
.
Anyone registered as an orthotist would have to meet this standard and we
could take action against them if they were not meeting the standard. So,
if an orthotist was advertising a particular treatment they should make
sure that their advertising was not misleading, false, unfair or
exaggerated. Although there is no specific statement about advertising
which went against established guidance, such as that from the Department
of Health, the general principles within the standard could still be
applied to this situation. The orthotist advertising the treatment would
need to demonstrate that the treatment was appropriate for the conditions
it was being advertised for. In addition, they would also need to
demonstrate that the treatment was appropriate for any particular patient
that they offered it to. If you have concerns that the orthotist is making
false advertising claims, you can raise those concerns with our fitness to
practise department: http://www.hpc-uk.org/complaints/.
Although we regulate individual orthotists, we do not regulate the
provision of services, in this case, the companies themselves. If you have
concerns about false or misleading advertising being undertaken by the
companies, you can contact the Advertising Standards Authority:
I hope that this answers your question but if you need anything further
please get in touch.
Best wishes,
Charlotte Urwin
Policy Manager
Policy & Standards department
Health Professions Council
Court Cases in the US in which the Courts ruled that the treatment for Plagiocephaly was not a cosmetic only treatment
SUZANNE BYNUM, Plaintiff-Appellee,
v.
CIGNA HEALTHCARE OF NORTH CAROLINA, INCORPORATED,
Defendant-Appellant.
JAMES 14 v. STATE OF SOUTH CAROLINA EMPLOYEE INSURANCE PROGRAM
Link to Plagiocephaly Advice from Great Ormond Street
Response from NHS Bristol regarding funding for Plagiocephaly Treatment
FOI 1011 367
Summary Issue – Plagiocephaly
Question
I am aware that Bristol PCT is providing treatment for children with
Plagiocephaly. I know that the helmets are provided by Frenchay
Hospital. As I am sure you are aware most PCT's in the UK do not
provide treatment on the NHS for plagiocephaly. I am wondering if you
could advise why Bristol have decided the treatment should be offered
to babies in your area?
Response
This is not a Bristol only service
It is a regional service commissioned by the South West
Specialised Commissioning Group for the South West
and provided by North Bristol NHS Trust at Frenchay
Hospital. The cost of the helmet is included in the total
procedure cost and there is no additional cost to the
commissioner.
The moulding cap treatment at Frenchay was set up
originally for post-operative treatment for babies having
cranial remodelling procedures for delayed diagnosis -
synostosis, but has been used for many years to treat
babies with severe plagiocephaly that has not
responded to standard postural measures. North Bristol
NHS Trust believe sufficient evidence exists to support
the technique in reducing the risk of long term cranial
deformity and avoiding a few of them having big
craniofacial remodelling operations
The information provided in this response is accurate as of 28 March 2011
Kat Tucker
Complaints & FOI Manager
NHS Bristol
0117 900 2494